Histopathologic Findings in Ascending Aortas From Individuals With Loeys-Dietz Syndrome (LDS)

Loeys-Dietz syndrome (LDS) is an autosomal dominant connective tissue disorder resulting from genetic mutations in the transforming growth factor β receptors 1 and 2 (TGFBR1 and TGFBR2). The syndrome is characterized phenotypically by hypertelorism, bifid uvula, and/or cleft palate, and arterial tortuosity with aneurysms and dissections. LDS has a much more rapid clinical course than Marfan syndrome (MFS) and thus those diagnosed with LDS are currently being recommended for prophylactic aortic root replacement at younger ages and with smaller aortic dimensions. Aortic root tissue obtained at surgery was compared between 15 patients carrying a diagnosis of LDS, 11 patients with MFS and 11 control aortas to evaluate the range of histopathologic changes in LDS. Standard hematoxylin and eosin and Movat pentachrome stains were performed. LDS samples had increased medial collagen and a subtle but diffuse form of elastic fiber fragmentation and extracellular matrix deposition, referred to as diffuse medial degeneration. LDS samples had significantly more diffuse medial degeneration compared with MFS and control samples (P<0.05), significantly less medial degeneration of the “cystic” variety compared with MFS (P<0.01) and significantly more collagen deposition than control samples (P<0.01). Additionally, an immunohistochemical stain for pSmad2, a marker of TGFβ activity, was significantly increased in LDS patients compared with controls (P<0.001). Overall, the histologic findings of LDS are best appreciated with special stains to evaluate fibrosis and elastic fiber fragmentation. The changes described, although not entirely specific for LDS, help differentiate this entity from other vascular diseases in the appropriate clinicopathologic setting.

[1]  D. Judge,et al.  Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states , 2007, Nature Medicine.

[2]  H. Dietz,et al.  Perturbations of Vascular Homeostasis and Aortic Valve Abnormalities in Fibulin-4 Deficient Mice , 2007, Circulation research.

[3]  V. Gott,et al.  Early surgical experience with Loeys-Dietz: a new syndrome of aggressive thoracic aortic aneurysm disease. , 2007, The Annals of thoracic surgery.

[4]  C. Kielty,et al.  Fibrillin-1 regulates the bioavailability of TGFβ1 , 2007, The Journal of cell biology.

[5]  H. Snieder,et al.  Ethnic and Gender Differences in Ambulatory Blood Pressure Trajectories: Results From a 15-Year Longitudinal Study in Youth and Young Adults , 2006, Circulation.

[6]  P. Byers,et al.  Aneurysm syndromes caused by mutations in the TGF-beta receptor. , 2006, The New England journal of medicine.

[7]  D. Koumoundourou,et al.  Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injury , 2006, Journal of cellular and molecular medicine.

[8]  W. Edwards,et al.  Surgical Pathology of the Ascending Aorta: A Clinicopathologic Study of 513 Cases , 2006, The American journal of surgical pathology.

[9]  George H. Thomas,et al.  Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor , 2006 .

[10]  J. Coselli,et al.  Increased Collagen Deposition and Elevated Expression of Connective Tissue Growth Factor in Human Thoracic Aortic Dissection , 2006, Circulation.

[11]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[12]  H. Dietz,et al.  Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome , 2006, Nature Genetics.

[13]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[14]  D. Judge,et al.  TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome , 2004 .

[15]  V. Kaartinen,et al.  Fibrillin controls TGF-β activation , 2003, Nature Genetics.

[16]  D. Arking,et al.  Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.

[17]  I. Aleksic,et al.  Chest Re-exploration for Complications after Lung Surgery , 1999, The Thoracic and cardiovascular surgeon.

[18]  R. Yozu,et al.  Prognosis of Marfan and non-Marfan patients with cystic medial necrosis of the aorta. , 1999, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[19]  E. Vanmechelen,et al.  Postmortem changes in the phosphorylation state of tau-protein in the rat brain , 1998, Neurobiology of Aging.

[20]  N. Kouchoukos,et al.  Sensitive detection of abnormal aortic architecture in Marfan syndrome with high-frequency ultrasonic tissue characterization. , 1995, Circulation.

[21]  R. Devereux,et al.  Two-dimensional echocardiographic aortic root dimensions in normal children and adults. , 1989, The American journal of cardiology.

[22]  J. Uitto,et al.  Marfan's syndrome: structural, biochemical, and mechanical studies of the aortic media. , 1985, The Journal of laboratory and clinical medicine.

[23]  D. Cooley,et al.  The morphology of ascending aortic aneurysms. , 1983, Human pathology.

[24]  R. Eisenstein,et al.  Aortic lesion in Marfan syndrome: the ultrastructure of cystic medial degeneration. , 1977, Archives of pathology & laboratory medicine.

[25]  J. Erdheim,et al.  Medionecrosis aortae idiopathica cystica , 1930, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.

[26]  D. Judge,et al.  TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. , 2004, The Journal of clinical investigation.

[27]  D. Arking,et al.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.

[28]  A. Becker,et al.  Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. , 1977, The American journal of cardiology.

[29]  A. Becker,et al.  Pathogenesis of dissecting aneurysm of aorta. Comparative histopathologic study of significance of medial changes. , 1977, The American journal of cardiology.